USB drive with patient info missing from IU Health hospital
Officials with an Indiana University Health emergency department say the missing flash drive contains information from more than 29,000 patients.
Health Care
Articles
Lilly’s 2016 sales, profit guidance falls short of predictions
Indianapolis-based Eli Lilly and Co., which has promised to return to growth after a half-decade of falling revenue, indicated that 2016 earnings might be below analysts’ estimates.
First-of-a-kind drug approvals continued rise in 2015
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
Family keeps up legal fight against Indiana malpractice cap
A jury awarded $15 million in damages to Crystal and Jamie Bobbitt in their lawsuit against a doctor and a hospital. They’ve not yet received any of that money, and their attorneys are challenging the constitutionality of the state’s malpractice law.
IBJ’s most-read stories of 2015
Despite national attention paid to RFRA and Jared Fogle, most of IBJ’s top-read online stories this year were the result of deeply sourced reporting on people, issues and businesses specific to central Indiana.
Longtime Riverview Health CEO planning retirement
Pat Fox, president and CEO of Riverview Health since 2004, plans to retire in May, the Noblesville-based health care network announced Monday.
Monroe becomes 4th county to use needle exchange
To launch a needle exchange program, community officials must convince the state it has a hepatitis C or HIV outbreak.
Lilly could pay $800M-plus in pact with drug-tech firm
The companies will work on coupling therapies from Lilly with technology from Halozyme Therapeutics that helps the body disperse and spread medicine.
IU Health shuffles execs in advance of Evans’ retirement
The state’s largest hospital system will promote IU Health Arnett President Al Gatmaitin president to chief operating officer, replacing Dennis Murphy, who is set to become CEO in April.
FDA OKs once-a-day insulin that could be blockbuster for Lilly
The FDA said Wednesday it approved Basaglar based on data showing it is safe and effective and works similarly to Lantus, the world’s top-selling insulin.
New psych hospital in Indy marks break with ‘failing model’
The Pence administration’s decision to spend $120 million on a new psychiatric hospital represents a stark shift from the state’s approach to mental health of the past 30 years.
Obamacare sign-up deadline extended by two days
As the Affordable Care Act enters its third year with enrollment well behind schedule, procrastinators are critical to its economic viability.
Autism likelier when antidepressants taken during pregnancy
A new study says women who took a common class of antidepressants during the second and third trimesters were more than twice as likely than other women to have children who later developed autism.
Lawmakers offer alternative to cold medicine sales crackdown
Two Indiana lawmakers have unveiled a proposal that they say will curb illegal sales of a common cold medicine used to make methamphetamine but would not penalize sick people by requiring prescriptions for the drug.
Former state health chief to head CDC Foundation
Former Indiana State Health Commissioner Judith A. Monroe has been named president and CEO of the Atlanta-based CDC Foundation, the organization announced Monday.
Startup for therapeutic gear raises $3M on way to market
Fishers-based Recovery Force LLC, which develops high-tech compression wearables for medical patients, athletes and military members, is working toward FDA approval.
Lilly separating manufacturing of animal health drugs
Eli Lilly and Co. is in the process of separating the manufacturing of its animal health drugs from the facilities used to make its traditional pharmaceuticals, a move that potentially could make it easier to spin off the division one day.
Eli Lilly ends development of promising insulin drug
Eli Lilly said Friday that it decided to stop developing the insulin peglispro after learning that it would take more time and cost more than expected to understand a significant side effect.
Investors betting no on Anthem mega-deal
Lots of investors are betting health insurance giants Anthem Inc. and Cigna Corp. won’t ever make it to the altar—an outlook driven by concerns antitrust regulators or other obstacles will prevent consummating the $45 billion deal.
Pence objects to new federal review of HIP program
Gov. Mike Pence fired off a letter to the Obama administration on Thursday asking it to cancel its contract with what he described as biased contractors recently hired to evaluate the Healthy Indiana Plan.